Lv3
290 积分 2025-09-23 加入
OP0054 RATES OF CONCURRENT BMD RESPONSES AT THE LUMBAR SPINE AND TOTAL HIP IN PATIENTS RECEIVING ROMOSOZUMAB OR TERIPARATIDE FOLLOWING BISPHOSPHONATE THERAPY: A POST HOC ANALYSIS OF THE RANDOMISED PHASE 3 STRUCTURE TRIAL
1个月前
已关闭
A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosis
1个月前
已关闭
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1个月前
已完结
A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium
1个月前
已关闭
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss
1个月前
已关闭
Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin
1个月前
已关闭
THE EFFECT OF DIFFERENT DOSES OF CALCITONIN ON BONE MINERAL DENSITY AND FRACTURE RISK IN POSTMENOPAUSAL OSTEOPOROSIS
1个月前
已完结
COMPARISON OF ALENDRONATE, CALCITONIN AND CALCIUM TREATMENTS IN POSTMENOPAUSAL OSTEOPOROSIS
1个月前
已完结
皖公网安备34019202002308
